5 Key Takeaways

• 1

  A study analyzed 419 patients with giant cell arteritis (GCA) to assess the efficacy of intravenous methylprednisolone (IVMP) for visual complications.

• 2

  The IVMP group received an average of three doses during the initial treatment phase, followed by oral glucocorticoids (OGC).

• 3

  No significant differences in overall survival or comorbidity rates were observed between the IVMP and OGC groups over a mean follow-up of 6.6 years.

• 4

  Only 20% of patients on IVMP showed meaningful visual acuity improvement, with no statistical difference from the OGC group.

• 5

  Patients over 80 years old treated with IVMP had a higher incidence of adverse effects, including hyperglycemia and new-onset diabetes mellitus.